Infex Therapeutics and LifeArc in Collaboration to Defeat Superbugs
Infex Therapeutics has combined forces with medical research charity, LifeArc,…
Introducing Infex Therapeutics
The organisation leading UK efforts to tackle the health crisis around our…
Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award
The AMR Centre has combined forces to attract much needed investment to…
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action The…
AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
Alderley Park, UK The AMR Centre has nominated a preclinical candidate in…
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese…
The AMR Centre secures £2.3m funding boost
The AMR Centre, a body with public and private investors leading the UK’s…
AMR Centre hails government action plan as ‘critical step’ in tackling antibiotic crisis
The AMR Centre has today welcomed the UK Government’s announcement of a new…
International Trade Minister visits AMR Centre
Alderley Park in Cheshire offers facilities for research & development…